Lyka Labs Limited
LYKALABS.BO - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.63B
Close$
$9.09
88.2% downside
Current Fair Value
88.2% downsideOvervalued by 88.2% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $2.63 Billion |
|---|---|
| Enterprise Value | - |
| Earnings per Share | $-2.81 |
| Beta | 0.16 |
| Outstanding Shares | 36,152,700 |
Return
| Return on Equity | NaN% |
|---|---|
| Return on Assets | NaN% |
| Return on Invested Capital | NaN% |
Valuation & Multiples
| P/E Ratio | -29.06 |
|---|---|
| PEG | -23.93 |
| Price to Sales | 2.03 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | - |
| Enterprise Value to Net Income | - |
| Total Debt to Enterprise | - |
| Debt to Equity | - |
Revenue Sources
No data
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
About Lyka Labs Limited
648 employees
CEO: Kunal Narendra Gandhi
Lyka Labs Limited is an Indian pharmaceutical firm engaged in the development, production, and commercialization of both pharmaceutical formulations and active pharmaceutical ingredients (APIs). Its operations span diverse therapeutic ar...